^
BIOMARKER:
MLH1 deletion
i
Other names: MLH1, COCA2, FCC2, HNPCC, HNPCC2, MutL homolog 1
Entrez ID:
›
MLH1 deletion
|
Endometrial Cancer
|
MLH1 deletion
|
Endometrial Cancer
|
nivolumab Sensitive: C3 – Early Trials
|
nivolumab Sensitive: C3 – Early Trials
|
MLH1 deletion
|
Prostate Cancer
|
MLH1 deletion
|
Prostate Cancer
|
nivolumab Sensitive: C3 – Early Trials
|
nivolumab Sensitive: C3 – Early Trials
|
MLH1 deletion
|
Colon Cancer
|
MLH1 deletion
|
Colon Cancer
|
cetuximab Resistant: D – Preclinical
|
cetuximab Resistant: D – Preclinical
|
